MetLife Investment Management, LLC - BIOCRYST PHARMACEUTICALS INC ownership

BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 234 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.15 and the average weighting 0.2%.

Quarter-by-quarter ownership
MetLife Investment Management, LLC ownership history of BIOCRYST PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$689,316
+0.6%
97,3610.0%0.01%0.0%
Q2 2023$685,421
-15.6%
97,3610.0%0.01%
-16.7%
Q1 2023$811,991
-27.4%
97,3610.0%0.01%
-33.3%
Q4 2022$1,117,704
-8.9%
97,3610.0%0.01%
-18.2%
Q3 2022$1,226,749
+19.1%
97,3610.0%0.01%
+37.5%
Q2 2022$1,030,079
-34.9%
97,3610.0%0.01%
-20.0%
Q1 2022$1,583,090
+84.3%
97,361
+57.0%
0.01%
+42.9%
Q4 2021$858,894
-3.6%
62,0140.0%0.01%
-12.5%
Q3 2021$891,141
-17.3%
62,014
-9.0%
0.01%
-20.0%
Q2 2021$1,077,926
+55.5%
68,1800.0%0.01%
+42.9%
Q1 2021$693,391
+27.8%
68,180
-6.4%
0.01%
+16.7%
Q4 2020$542,733
+125.5%
72,850
+4.0%
0.01%
+100.0%
Q3 2020$240,728
-27.9%
70,0810.0%0.00%
-25.0%
Q2 2020$333,936
+327.1%
70,081
+79.3%
0.00%
+300.0%
Q1 2020$78,178
-67.8%
39,089
-44.5%
0.00%
-66.7%
Q4 2019$243,049
+67.7%
70,449
+39.3%
0.00%
+50.0%
Q3 2019$144,935
-24.4%
50,5880.0%0.00%0.0%
Q2 2019$191,729
-53.4%
50,5880.0%0.00%
-60.0%
Q1 2019$411,786
+0.9%
50,5880.0%0.01%0.0%
Q4 2018$408,245
+5.8%
50,5880.0%0.01%
+25.0%
Q3 2018$385,986
+56.9%
50,588
+18.0%
0.00%
+33.3%
Q2 2018$246,000
+20.0%
42,8810.0%0.00%
+50.0%
Q1 2018$205,000
-2.8%
42,8810.0%0.00%0.0%
Q4 2017$211,00042,8810.00%
Other shareholders
BIOCRYST PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Burrage Capital Management LLC 1,105,673$8,237,0006.28%
Sarissa Capital Management LP 8,175,000$60,903,0006.22%
ORACLE INVESTMENT MANAGEMENT INC 2,980,870$22,207,0002.78%
DG Capital Management, LLC 1,075,732$8,014,0001.70%
Ghost Tree Capital, LLC 900,000$6,705,0001.49%
Parkman Healthcare Partners LLC 538,370$4,011,0001.03%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 5,835,810$43,477,0000.86%
Formidable Asset Management, LLC 470,419$3,470,0000.80%
KNOTT DAVID M 219,461$1,635,0000.74%
Altium Capital Management LP 250,000$1,863,0000.70%
View complete list of BIOCRYST PHARMACEUTICALS INC shareholders